ACADIA Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
All right. Good afternoon or good morning from the virtual JPMorgan Healthcare Conference. My name is Cory Kasimov, I'm the senior large-cap biotech analyst, and it's my pleasure to introduce our next company ACADIA Pharmaceuticals and CEO, Steve Davis. Please note that following this presentation, we will have a Q&A session where you have the ability to submit questions via the little blue button in your conference portal.
So with that, Steve, thanks for being here today, and let me turn things over to you.
Great. Thanks much, Cory. Hello, everyone, and thank you for joining us today. I'm Steve Davis, CEO of Acadia Pharmaceuticals. Just a brief reminder that the business of pharmaceutical development and commercialization has certain inherent risks. So please refer to Slide 2 of this presentation and a copy of our most recent SEC filings for a description of those risks as they relate
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |